IOL Chemicals & Pharma gets nod for 2 APIs

This will strengthen the company's presence in the South Korean market, it added.

78
Medicines
Picture: Pixabay

Last Updated on October 16, 2021 by The Health Master

New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products:

Ibuprofen and
Fenofibrate.

The approval by the Korean Ministry of Food and Drug Safety re-establishes the company’s efforts to keep the highest quality standards and to increase presence in the regulated markets, IOL Chemicals & Pharmaceuticals said in a regulatory filing.

This will strengthen the company’s presence in the South Korean market, it added.

Ibuprofen is used to treat a range of aches and pains, including back pain, period pain and toothache. Fenofibrate is used to treat the symptoms of high cholesterol and triglycerides in the blood.

Shares of the company closed at Rs 607.55 apiece on BSE, up 1.37 per cent over previous close.

Govt notifies MTP Rules 2021 for abortion up to 24 weeks

NPPA releases proposed retail price calculation for 7 formulations

KSRP urges Govt and PCI to amend admission process to the…

USFDA Staff: Moderna did not meet all criteria for booster dose

Biological E seeks DCGI nod for Phase-III trial of Corbevax

Latest Notifications: Homoeopathic

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner